Diagnostic Accuracy for Lupus and Other Systemic Autoimmune Diseases in the Community Setting
Authors:
- Sonali NarainSNSonali Narain
- Hanno B. RichardsHRHanno B. Richards
- Minoru SatohMSMinoru Satoh
- Marlene SarmientoMSMarlene Sarmiento
- Richard DavidsonRDRichard Davidson
- Jonathan ShusterJSJonathan Shuster
- Eric SobelESEric Sobel
- Paulette HahnPHPaulette Hahn
- Westley H. ReevesWRWestley H. Reeves
Open Access
- 13 December 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (22) , 2435-2441
Abstract
The diagnoses of systemic lupus erythematosus (SLE), progressive systemic sclerosis, and Sjögren syndrome are aided by well-established clinical criteria.1-5 Since many patients with these potentially serious diseases undergo evaluation and treatment initially by community physicians, it is important that they be recognized so that affected individuals can be referred to specialists in a timely manner. Misdiagnosis can have a serious negative impact on health as well as economic and emotional consequences. The risks of overdiagnosis include inappropriate treatment with potentially dangerous medications, unnecessary referrals6,7 and laboratory tests,8 and difficulty obtaining health or life insurance. Conversely, underdiagnosis can lead to a delay in appropriate therapy, culminating in irreversible complications such as renal failure or pulmonary fibrosis. Because an accurate and timely diagnosis can reduce health care costs, the need to train primary care physicians in rheumatological diagnosis has been increasingly recognized.9Keywords
This publication has 1 reference indexed in Scilit:
- Development of Autoantibodies before the Clinical Onset of Systemic Lupus ErythematosusNew England Journal of Medicine, 2003